Potential biomarkers of monocyte/macrophage activity in a patient with sarcoidosis, treated with infliximab.

Bristol Eye Hospital, University Hospitals Bristol NHS Foundation Trust, Bristol, UK, Casey Eye Institute, Oregon Health & Science University, Portland, OR, USA, Department of Paediatric Rheumatology, DuPont Hospital for Children, Wilmington, DE, USA, Department of Cellular and Molecular Medicine, School of Medical Sciences, University of Bristol, Bristol, UK and Department of Paediatric Rheumatology, Bristol Royal Hospital for Children, Bristol University Hospitals NHS Foundation Trust, Bristol, UK Accepted 25 November 2010 Correspondence to: Srilakshmi M. Sharma, Department of Neuroophthalmology, Wilmer Eye Institute, Johns Hopkins Hospital, 600 N Wolfe Street, Baltimore, MD 21287, USA. E-mail: [email protected]